Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses

被引:46
作者
Fan, Jia-Rong [1 ]
Peng, An-Lin [1 ]
Chen, Hsiang-Chin [1 ]
Lo, Shu-Chi [1 ]
Huang, Ting-Hsiang [1 ]
Li, Tsai-Kun [1 ]
机构
[1] Natl Taiwan Univ, Coll Med, Dept & Grad Inst Microbiol, Taipei 10018, Taiwan
关键词
DNA topoisomerase; etoposide; processing; DNA damage signaling; recombinational repair; degradation of cleavable complex;
D O I
10.1016/j.dnarep.2007.12.002
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Cytotoxic action (tumor cell killing) and carcinogenic side effect (therapy-related secondary leukemia) of etoposide are closely related to its ability in stabilizing topoisomerase II cleavable complex (TOP2cc), a unique form of protein-linked DNA break. How cells process and detect TOP2-concealed DNA damage for the activation of downstream cellular responses remains unclear. Here, we showed proteasomal degradation of both TOP2 isozymes in a transcription-dependent manner upon etoposide treatment. Downregulation of TOP2 was preferentially associated with proteasomal removal of TOP2 in TOP2cc rather than proteolysis of free TOP2. Interestingly, blockage of TOP2 downregulation in TOP2cc also caused reduction in etoposide-induced activation of DNA damage molecules, an observation suggesting that the processing pathways of TOP2cc are involved in activation of etoposide-induced cellular responses. In this regard, we observed two TOP2cc processing pathways, replication- and transcription-initiated processing (RIP and TIP) with proteasome involved in the latter. Importantly, two processing pathways contributed to differential activation of various DNA damage signaling and downstream cellular responses. Etoposide-induced phosphorylation of p53 relied mainly on RIP, whereas activation of Chk1, Chk2 depended largely on TIP. Both RIP and TIP played roles in activating non-homologous end joining pathway, while only RIP modulated etoposide -induced cell killing in a p53-dependent manner. Collectively, our results are consistent with the notion that protein-linked DNA breakage (e.g., TOP2cc) requires processing pathways for initiating downstream DNA damage detection, repair as well as cell death programs. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:452 / 463
页数:12
相关论文
共 53 条
  • [1] Hypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193 - Implications for the repair of topoisomerase II-mediated DNA damage
    Adachi, N
    Suzuki, H
    Iiizumi, S
    Koyama, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (38) : 35897 - 35902
  • [2] Genetic evidence for involvement of two distinct nonhomologous end-joining pathways in repair of topoisomerase II-mediated DNA damage
    Adachi, N
    Iiizumi, S
    So, S
    Koyama, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 318 (04) : 856 - 861
  • [3] Crystal structure of the topoisomerase II poison 9-amino-[N-(2-dimethylamino)ethyl]acridine-4-carboxamide bound to the DNA hexanucleotide d(CGTACG)2
    Adams, A
    Guss, JM
    Collyer, CA
    Denny, WA
    Wakelin, LPG
    [J]. BIOCHEMISTRY, 1999, 38 (29) : 9221 - 9233
  • [4] Catalytic inhibitors of DNA topoisomerase II
    Andoh, T
    Ishida, R
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3): : 155 - 171
  • [5] Chromosomal translocations involving the MLL gene:: Molecular mechanisms
    Aplan, Peter D.
    [J]. DNA REPAIR, 2006, 5 (9-10) : 1265 - 1272
  • [6] Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies
    Azarova, Anna M.
    Lyu, Yi Lisa
    Lin, Chao-Po
    Tsai, Yuan-Chin
    Lau, Johnson Yiu-Nam
    Wang, James C.
    Liu, Leroy F.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (26) : 11014 - 11019
  • [7] Mutagenic properties of topoisomerase-targeted drugs
    Baguley, BC
    Ferguson, LR
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3): : 213 - 222
  • [8] Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364
  • [9] Banáth JP, 2003, CANCER RES, V63, P4347
  • [10] Structure and mechanism of DNA topoisomerase II
    Berger, JM
    Gamblin, SJ
    Harrison, SC
    Wang, JC
    [J]. NATURE, 1996, 379 (6562) : 225 - 232